PF-AtlasClinical Trials › NCT06812793

Muscle Endurance in Children With Cystic Fibrosis

Measurement of Core Muscle Endurance · Not specified

Registry ID
NCT06812793
Phase
Not specified
Status
Completed
Drug / intervention
Measurement of Core Muscle Endurance
Sponsor
Bezmialem Vakif University
Start
2025-02-05
Enrollment
48
Locations
1

About this trial

Cystic fibrosis (CF) is a genetic disorder affecting exocrine glands, leading to thick, viscous secretions that damage organs such as the lungs, pancreas, and reproductive system. Respiratory failure from CF lung disease is a major cause of morbidity and mortality, with chronic inflammation and infections disrupting mucociliary clearance. This results in declining respiratory functions, muscle strength, physical inactivity, and quality of life. While some studies compare respiratory and lower extremity muscle endurance in children with CF, none have evaluated core muscle endurance. This study aims to compare respiratory muscle strength, endurance, and muscle endurance in the core and lower extremities between children with CF and healthy peers.

View NCT06812793 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT06812793 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.